Shahin RafiiMD, PhD
Dr. Shahin Rafii, M.D., Ph.D., is the Arthur B. Belfer Professor of Genetic Medicine of Weill-Cornell Medical College. Dr. Rafii has been Professor in Genetic Medicine since 2002, at which time he was appointed to be the Co-Director of the Ansary Stem Cell Research Center in New York. He served as faculty of Cornell Medical College in 1994. He is a world-renowned stem cell researcher from Cornell University Medical College, New York.
He is a board certified Hematologist-Oncologist, is engaged in patient care and basic and translational research. He was appointed to spearhead the Ansary Stem Cell Center for Regenerative Medicine at Weill-Cornell. He was elected to Howard Hughes Medical Institute. He has been a Member of Scientific and Clinical Advisory Board at Chemokine Therapeutics Corporation. Dr. Rafii serves as a Member of Scientific Advisory Board at Juventas Therapeutics, Inc. Dr. Rafii served as a Member of Scientific Advisory Board at AngioGenex, Inc.
He holds a MD degree from Albert Einstein College of Medicine with Honors and was elected to AOA society in 1986. In 1989, he completed his internship and residency in Internal Medicine followed by a fellowship in Hematology-Oncology at Weill-Cornell in 1992. By 1996, he completed his post-doctoral training in vascular and hematopoietic stem cell biology at Weill-Cornell. Dr. Rafii graduated from Cornell University in 1982, with a Bachelors degree of Cum Laude in Chemistry and was awarded Phi Beta Kappa.